Perilipin as a target for regulation of body weight, muscle mass and diabetes
CA 2425789 A1 · Owner: Chan, Lawrence · Inventors: Chan, Lawrence
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to screening assays to identify compounds that modulate the activity or expression of perilipin. The present invention also relates to methods and therapeutic compositions for the prevention or treatment of body weight disorders or diabetes comprising administering to subjects compounds that modulate the activity or expression of perilipin. In one aspect, the invention of perilipin in order to treat and/or prevent obesity or diabetes, and to enhance lipid metabolism and muscle mass. In another aspect, the invention relates to methods and compositions that agonize the activity of perilipin in order to enhance lipid accumulation in a subject in order to …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 5, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 5, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 5, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.